Vericel (VCEL) Competitors $43.36 +0.81 (+1.91%) As of 01:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VCEL vs. BPMC, BBIO, VRNA, ROIV, RVMD, ELAN, LEGN, TGTX, GRFS, and LNTHShould you be buying Vericel stock or one of its competitors? The main competitors of Vericel include Blueprint Medicines (BPMC), BridgeBio Pharma (BBIO), Verona Pharma PLC American Depositary Share (VRNA), Roivant Sciences (ROIV), Revolution Medicines (RVMD), Elanco Animal Health (ELAN), Legend Biotech (LEGN), TG Therapeutics (TGTX), Grifols (GRFS), and Lantheus (LNTH). These companies are all part of the "pharmaceutical products" industry. Vericel vs. Its Competitors Blueprint Medicines BridgeBio Pharma Verona Pharma PLC American Depositary Share Roivant Sciences Revolution Medicines Elanco Animal Health Legend Biotech TG Therapeutics Grifols Lantheus Vericel (NASDAQ:VCEL) and Blueprint Medicines (NASDAQ:BPMC) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends. Do analysts recommend VCEL or BPMC? Vericel currently has a consensus target price of $61.14, suggesting a potential upside of 40.97%. Blueprint Medicines has a consensus target price of $128.06, suggesting a potential downside of 0.25%. Given Vericel's stronger consensus rating and higher probable upside, research analysts plainly believe Vericel is more favorable than Blueprint Medicines.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vericel 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Blueprint Medicines 0 Sell rating(s) 17 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.27 Which has higher earnings & valuation, VCEL or BPMC? Vericel has higher earnings, but lower revenue than Blueprint Medicines. Blueprint Medicines is trading at a lower price-to-earnings ratio than Vericel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVericel$237.22M9.20$10.36M$0.031,445.80Blueprint Medicines$508.82M16.29-$67.09M-$2.47-51.98 Which has more risk & volatility, VCEL or BPMC? Vericel has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, Blueprint Medicines has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Is VCEL or BPMC more profitable? Vericel has a net margin of 1.25% compared to Blueprint Medicines' net margin of -27.70%. Vericel's return on equity of 1.09% beat Blueprint Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Vericel1.25% 1.09% 0.73% Blueprint Medicines -27.70%-64.60%-17.22% Does the media prefer VCEL or BPMC? In the previous week, Blueprint Medicines had 7 more articles in the media than Vericel. MarketBeat recorded 9 mentions for Blueprint Medicines and 2 mentions for Vericel. Vericel's average media sentiment score of 1.87 beat Blueprint Medicines' score of 1.23 indicating that Vericel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vericel 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Blueprint Medicines 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryVericel beats Blueprint Medicines on 11 of the 15 factors compared between the two stocks. Get Vericel News Delivered to You Automatically Sign up to receive the latest news and ratings for VCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCEL vs. The Competition Export to ExcelMetricVericelMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.19B$2.88B$5.52B$8.87BDividend YieldN/A2.70%5.36%4.13%P/E Ratio1,447.3821.6626.5019.82Price / Sales9.20267.10410.19110.66Price / Cash133.5441.2925.8827.49Price / Book7.337.277.945.39Net Income$10.36M-$55.05M$3.15B$248.34M7 Day Performance0.08%-0.47%1.08%1.25%1 Month Performance3.64%6.59%5.34%5.41%1 Year Performance-3.68%0.42%32.80%18.07% Vericel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCELVericel2.8949 of 5 stars$43.37+1.9%$61.14+41.0%-7.3%$2.19B$237.22M1,447.38300Positive NewsBPMCBlueprint Medicines1.7401 of 5 stars$128.40+0.2%$128.06-0.3%+18.9%$8.29B$508.82M-51.98640Positive NewsHigh Trading VolumeBBIOBridgeBio Pharma4.6898 of 5 stars$42.17+1.1%$56.67+34.4%+70.5%$8.01B$127.42M-11.95400Analyst ForecastInsider TradeVRNAVerona Pharma PLC American Depositary Share2.5699 of 5 stars$97.05+2.9%$101.10+4.2%+554.1%$7.87B$118.54M-48.5330Positive NewsAnalyst ForecastGap UpROIVRoivant Sciences2.0596 of 5 stars$11.50+0.4%$17.50+52.2%+6.6%$7.82B$29.05M-46.00860RVMDRevolution Medicines4.4565 of 5 stars$40.04+1.0%$67.08+67.5%-5.2%$7.46B$11.58M-10.01250ELANElanco Animal Health2.3362 of 5 stars$13.36-0.7%$15.17+13.5%-1.0%$6.64B$4.43B18.059,000LEGNLegend Biotech2.4079 of 5 stars$33.85-0.4%$76.20+125.1%-19.9%$6.22B$627.24M-57.372,609Positive NewsTGTXTG Therapeutics3.7388 of 5 stars$36.56+1.5%$40.80+11.6%+102.3%$5.80B$329M152.33290GRFSGrifols4.0604 of 5 stars$8.37-4.6%$10.30+23.1%+43.4%$5.75B$7.81B7.1523,822Analyst DowngradeLNTHLantheus4.3887 of 5 stars$80.81+2.0%$130.50+61.5%+2.0%$5.59B$1.53B22.96700 Related Companies and Tools Related Companies BPMC Competitors BBIO Competitors VRNA Competitors ROIV Competitors RVMD Competitors ELAN Competitors LEGN Competitors TGTX Competitors GRFS Competitors LNTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VCEL) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vericel Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Vericel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
